Body contouring marketing rules: fat reduction, inch loss and device claims

Non-surgical body contouring is sold by med spas, plastic surgery practices, dermatology offices and weight loss clinics under many names: fat freezing, body sculpting, inch loss, skin tightening, muscle toning, cellulite reduction. The marketing for these services tends to promise a visible change in a set number of sessions, often next to before-and-after photos. Each part of that promise is a claim the clinic has to be able to support.

This guide covers how FDA describes non-invasive body contouring, how to describe your device and its cleared uses, why “weight loss” is the wrong frame, and how the FTC Act applies to result claims, photos and testimonials. For device wording across specialties, see our guide to medical device marketing claims. For broader promotion ideas, see med spa marketing ideas. For laser hair reduction claims, see our guide to laser hair removal marketing. For why injectable fillers should not be advertised for buttock or breast enhancement, see our guide to dermal filler advertising rules. For injections sold to dissolve fat, see our guide to fat-dissolving injection marketing. Vibration platforms sold for fat loss are covered in our guide to whole body vibration marketing claims. Lipedema surgery is covered in our guide to lipedema treatment marketing.

The short version

• It is not weight loss. FDA says non-invasive body contouring “does not treat obesity or improve your health” and “will not result in weight loss or contribute to the health benefits associated with weight loss.” Keep it out of weight loss ads and weight loss language.
• Claims follow your device’s authorization. FDA reviews these devices “for the intended uses and body sites on which the device is intended for use.” A body area or effect outside your device’s cleared or authorized use is a claim FDA has not reviewed.
• No breast contouring claims. FDA says there are no cleared or approved non-invasive body contouring devices for treating the breasts in males or females.
• “FDA-cleared”, not “FDA-approved”. Several of these device types are Class II devices that reach the market through 510(k), and 21 CFR 807.97 says a clearance does not denote official approval.
• Results vary and may be temporary. FDA says not everyone responds, results may be temporary and more than one treatment may be needed. Ads that promise a fixed result or permanence need evidence you are unlikely to have.
• Testimonials and photos are claims too. Under 16 CFR 255.2, a featured result is read as typical unless you clearly disclose what patients generally achieve.

What FDA says body contouring is, and is not

FDA’s Non-Invasive Body Contouring Technologies page describes body contouring as changing the shape of an area of the body, including changing the circumference of an area such as the waist or thighs, reducing small areas of fat, improving the tone and firmness of certain muscles, and improving the appearance of cellulite. Non-invasive procedures “do not remove any tissue (fat or skin) from the body” and are performed on the skin surface without incisions.

The same page sets three limits that matter for marketing. First, body contouring is not a weight loss or health treatment: it “does not treat obesity or improve your health” and “will not result in weight loss.” Second, “there are no FDA cleared or approved non-invasive body contouring devices for treating the breasts in males or females.” Third, results are not guaranteed: “body contouring procedures may not always result in your desired effect, or your result may only be temporary,” and FDA tells patients to ask how many treatments will be needed and how long effects are expected to last. FDA also calls non-invasive body contouring “a medical procedure with benefits and risks,” even though it “may be performed in a variety of facilities.”

For a clinic, that means a service page should talk about shape, contour, circumference or the look of a specific area, not pounds, health or a slimmer body overall. If you also run a medical weight loss program, keep the two offers clearly separate, and do not present contouring as part of weight loss treatment. Our guide to weight loss clinic marketing covers the rules for weight loss claims themselves.

Describe your device by what it was authorized for

FDA groups the technologies it has reviewed by how they work: cold (cryolipolysis, or fat freezing), heat from radiofrequency energy, light-based energy such as lasers, therapeutic ultrasound, low-level light (photobiomodulation), pulsed magnetic fields that cause muscle contractions, and mechanical massage or vibration. Each device on the market was reviewed for specific intended uses and body sites.

Some of these device types have their own classification regulations. A contact cooling system for aesthetic use, intended “for the disruption of adipocyte cells intended for non-invasive aesthetic use,” is a Class II device with special controls (21 CFR 878.4340). So is a focused ultrasound stimulator system for aesthetic use (21 CFR 878.4590) and a low level laser system for aesthetic use that disrupts fat cells “for the release of fat and lipids from these cells” (21 CFR 878.5400). For any device, the authoritative description of what it is cleared or authorized for is its own 510(k) or De Novo summary in FDA’s databases, which FDA says include “the indication for which the device was authorized.”

Practical rules for your pages and ads:

• Match the body area. If your device’s indication names the abdomen and flanks, a campaign for “arm fat” or “double chin” with that device goes beyond what FDA reviewed.
• Match the effect. A device authorized for temporary improvement in the appearance of cellulite is not a fat reduction device, and a muscle stimulation device is not a fat-freezing device. Describe each machine by its own indication.
• Say “FDA-cleared” only if true, and never “FDA-approved” for a cleared device. 21 CFR 807.97 says any representation that creates an impression of official approval because of a 510(k) clearance “is misleading and constitutes misbranding.”
• Do not borrow the maker’s clearance for your package. A clearance covers the device for its indication. It does not cover your combination package, your session count or a result you advertise.
• Home and over-the-counter claims. FDA says cryolipolysis devices “are for prescription use only” and that “the safety and effectiveness of over-the-counter or home use fat freezing has not been established.” Do not sell or suggest home fat freezing as an alternative to in-clinic treatment.

Result claims: inches, percentages, sessions and permanence

The FTC Act makes it unlawful to disseminate a false advertisement to induce the purchase of devices or services (15 USC 52). An advertisement is false if it is “misleading in a material respect,” and that includes failing to reveal facts material in light of what the ad says, or material to the consequences of using the product (15 USC 55(a)(1)). For body contouring, the claims that most often need attention are:

• Inch or percentage figures. “Lose 2 inches in one session” or “up to 25% fat reduction” are specific, measurable claims. You need evidence for the figure as stated, for the device and protocol you use. A number from a manufacturer’s brochure or a study of a different protocol does not substantiate your ad. If you have no such evidence, describe the treatment without a number.
• Permanence. FDA says results may be temporary. “Permanent fat loss” or “gone for good” overstates what you can show for a given patient.
• Session count. “One and done” or “results in a single visit” conflicts with FDA’s advice that patients may need more than one treatment. Say what a typical plan at your clinic involves and that the number of sessions varies.
• Risk and downtime. FDA lists common complications for all body contouring devices, including pain, redness, swelling, bruising and nodules, and more serious ones for specific technologies, such as burns for heat, light and ultrasound devices and paradoxical adipose hyperplasia (fatty tissue that grows instead of shrinking) for fat freezing, which FDA says may require surgery. “No risk” or “no side effects” leaves out facts that are material to the consequences of treatment (15 USC 55(a)(1)).
• Who is a candidate. FDA lists people who should not have specific procedures, such as people with cold sensitivity disorders for fat freezing and people with active implants such as pacemakers for radiofrequency, ultrasound and magnetic devices. “Safe for everyone” contradicts that.

Before-and-after photos and testimonials

Body contouring marketing relies on photos, and photos are endorsements of results. Under 16 CFR 255.2(a), an ad using consumer endorsements is read as representing that the product is effective for the purpose shown, and the advertiser needs substantiation as if it had made the claim directly. Under 16 CFR 255.2(b), an endorsement about a central attribute is likely to be read as representative of what consumers will generally achieve. If you cannot show that the featured result is typical, the ad should “clearly and conspicuously disclose the generally expected performance in the depicted circumstances,” and you need evidence for that disclosure too.

• Use only your own patients’ photos, taken with your device and protocol, with written consent.
• Keep lighting, pose, distance, clothing and time of day the same in before and after shots, and do not retouch the treated area.
• Label each pair with the device type, number of sessions and time since the last session.
• Do not pair body contouring photos with weight figures. A change in weight between photos makes the image misleading about what the procedure did.
• If a result is above what patients generally see at your clinic, say so and state what is typical.

For the rest of the rules on photos, see our guide to patient testimonials and before-and-after photos.

Paid ads and promotions

Search and social campaigns for body contouring are usually where the shortest, strongest claims appear, so apply the same checks to ad copy as to the service page. Avoid ad groups or audiences built around weight loss or obesity terms, since FDA says these procedures do not produce weight loss. Seasonal packages and “buy 3 get 1” offers are fine to promote if the price is real and the result language stays within the limits above. Our guide to Google Ads for med spas covers platform policy and campaign setup; we did not read ad platform policies for this guide.

An example (made up)

This illustration is invented to show how the rules fit together. A med spa’s landing page reads: “FDA-approved fat freezing. Lose up to 2 inches in one session. Permanent results, no downtime. Perfect for post-baby belly, arms and chest.” The ad runs on weight loss search terms, and the gallery shows a patient who also lost weight between photos.

Fixes: “FDA-approved” becomes “FDA-cleared for [the body areas in the device’s 510(k) summary]” (21 CFR 807.97). The inch figure goes, because the clinic has no study of its own protocol; the page now says results vary, may take two to three months to appear, and some patients need more than one session, in line with FDA’s page. “Permanent” and “no downtime” go; a short risks section lists common effects and links to FDA’s page. “Chest” goes, because FDA says no device is cleared or approved for treating the breasts, and “arms” stays only if the device’s indication includes it. Weight loss keywords are removed. The gallery pair with weight change is replaced with a consented pair labeled with sessions and timing, and a typical-results note is added (16 CFR 255.2(b)).

Checklist

• No weight loss, obesity or health benefit claims for body contouring (FDA body contouring page).
• Each device described by its own cleared or authorized indication and body sites (510(k) or De Novo summary).
• “FDA-cleared” only if true; never “FDA-approved” for a cleared device (21 CFR 807.97).
• No breast or chest contouring claims for any device.
• No inch or percentage figures without evidence for your device and protocol (15 USC 52, 55).
• No “permanent”, “one session”, “no risk” or “safe for everyone” promises.
• Common and device-specific risks and who is not a candidate stated where results are shown.
• Before-and-after photos are your own consented patients, standardized and labeled, with no weight change shown as a contouring result (16 CFR 255.2).
• Typical results disclosed when a featured result is not typical (16 CFR 255.2(b)).
• No home fat freezing products or claims; operator titles checked against your state’s rules.

How we help

We build service pages, treatment galleries and campaigns for med spas and aesthetic practices, with device, result and photo claims checked against the sources above: website design, healthcare SEO for local treatment searches, and lead generation campaigns. We do not give legal opinions on device status or state rules on who may operate these devices, and we are not a law firm.

Sources

• FDA: Non-Invasive Body Contouring Technologies (content current as of October 15, 2025)
• 21 CFR 878.4340: Contact cooling system for aesthetic use
• 21 CFR 878.4590: Focused ultrasound stimulator system for aesthetic use
• 21 CFR 878.5400: Low level laser system for aesthetic use
• 21 CFR 807.97: Misbranding by reference to premarket notification
• 15 USC 52: Dissemination of false advertisements
• 15 USC 55: Additional definitions
• 16 CFR 255.2: Consumer endorsements

More in Cash-pay, aesthetic and wellness care